NCP Flanders
choose your programme
Horizon Europe

Horizon Europe is the main Research and Innovation Funding Programme of the European Commission.

Horizon 2020

Horizon 2020 is the previous Funding Programme. There are no longer calls, but projects can run until 2024.

Digital Europe

Digital Europe is a Funding Programme focused on bringing digital technology to businesses, citizens and administrations.

Other EU Funding

There are many other relevant EU funding programmes, managed by several agencies and directorates.

Marie Sklodowska-Curie Actions (MSCA)

Marie Sklodowska-Curie Fellowships are European research grants available to researchers regardless of their nationality or field of research. The general objective is to stimulate the mobility of researchers.

Your NCP contact for this programme

Image of Margot Beereboom

Margot Beereboom

margot.beereboom@fwo.be

+32 2 550 15 76

About this programme

Marie Sklodowska-Curie Fellowships are European research grants available to researchers regardless of their nationality or field of research. In addition to generous research funding scientists have the possibility to gain experience abroad and in the private sector, and to complete their training with competences or disciplines useful for their careers.

The Marie Sklodowska-Curie programme aims to foster innovation, research-business cooperation and also includes a strong international component based on the principle of mobility.

The MSCA provides funding for all stages of research careers, being doctoral candidates or highly experienced researchers and by ensuring good working conditions and work/life balance for the researchers.

The programme is open to all fields of research and innovation, from fundamental research to market take-up and innovation services. Furthermore, it also encourages mobility between the different sectors (universities, research centres, and companies), disciplines and countries.

There are five types of Marie Sklodowska-Curie Actions:

  • Postdoctoral Fellowships (PF)
  • Doctoral Networks (DN)
  • Staff Exchange (SE)
  • Co-funding of regional, national and international doctoral and postdoctoral programmes (COFUND)
  • MSCA and Citizens - European Researchers’ Night
Click to read more 
Hide text 

Latest news

Upcoming events

Work Programme & Calls

We offer a handy Excel file, weekly updated, containing an up-to-date overview of the Horizon Europe calls. call topics overview

Infosheets

Infosheets contain edited content on aspects related to this programme. They are reviewed at least yearly.

    No infosheets available for this domain

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.